[1]
Drobniak , A. and Malik , L. 2022. ADT in prostate cancer treatment in 2022 – the choice or necessity?. Medycyna Faktow (J EBM). 15, 3(56) (Sep. 2022), 297-300. DOI:https://doi.org/10.24292/01.MF.0322.4.